3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
17
Fallopian Tube Neoplasms
17
Carcinoma, Non-Small-Cell Lung
8
Glioblastoma
7
Carcinoma, Renal Cell
7
Lung Neoplasms
6
Colorectal Neoplasms
6
Brenner Tumor
6
Squamous Cell Carcinoma of Head and Neck
5
Melanoma
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Gliosarcoma
4
Breast Neoplasms
4
Brain Neoplasms
4
Recurrent Squamous Cell Lung Carcinoma
3
Oligodendroglioma
3
Neoplasm Metastasis
3
Lymphoma, Large B-Cell, Diffuse
3
Uveal Melanoma
2
Urinary Bladder Neoplasms
2
Spinal Cord Neoplasms
2
Medulloblastoma
2
Glioma
2
Endometrial Adenocarcinoma
2
Colonic Neoplasms
2
Carcinoma
2
Astrocytoma
2
Adenocarcinoma of Lung
2
Interventions
Cisplatin
4
pembrolizumab
3
Nivolumab
3
Fluorouracil
2
Carboplatin
2
toripalimab
1
spartalizumab
1
fludarabine phosphate
1
fludarabine
1
cc-486
1
camrelizumab
1
Vorinostat
1
Valganciclovir
1
Range of Motion, Articular
1
Radiotherapy
1
Radiosurgery
1
Protons
1
Platinum
1
Methylprednisolone
1
Medicare Part B
1
Laryngoscopes
1
Gemcitabine
1
Docetaxel
1
Cyclophosphamide
1
Cetuximab
1
Bevacizumab
1
Azacitidine
1
Adrenal Cortex Hormones
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Nasopharyngeal Carcinoma
×
Immunoglobulin G
×
Clear all
No trials found.